Tallini et al. reported similar findings, showing that BRAF V600E-positive MPTC are linked to a subcapsular site of origin, thereby increasing the likelihood of developing aggressive anatomopathological features including lymph node metastases [31]. The gene discussed is BRAF; the disease is metastatic malignant neoplasm in the lymph nodes.